MedTrace Logo

Chronic Liver Disease in Urea Cycle Disorders

NCT03721367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2023-02-10

Study results available
· View outcomes & findings →

Summary

This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San Francisco, California and Seattle Children's Hospital, Seattle,Washington

Conditions

  • Urea Cycle Disorder

Interventions

OTHER

Diagnostic Ultrasound

All individuals will undergo a blood draw for measurement of biomarkers of liver disease and an ultrasound with shear-wave elastography.

Sponsors & Collaborators

Eligibility

Min Age
5 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-29
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721367 on ClinicalTrials.gov